CAS 257879-35-9

Formel: C24H21N5O2

InChl: InChI=1S/C24H21N5O2/c30-23-21(22(24(31)27-23)26-17-7-2-1-3-8-17)19-15-29(20-10-5-4-9-18(19)20)13-6-12-28-14-11-25-16-28/h1-5,7-11,14-16H,6,12-13H2,(H2,26,27,30,31)

InChI Key: KIWODJBCHRADND-UHFFFAOYSA-N

SMILES: C1=CC=C(C=C1)NC2=C(C(=O)NC2=O)C3=CN(C4=CC=CC=C43)CCCN5C=CN=C5

PKCβ inhibitor 1

CAS: 257879-35-9

PKCβ inhibitor 1

Formel: C₂₄H₂₁N₅O₂

Reinheit: ≥98%

Molekulargewicht: 411.46

Ref: 54-BUP04701

PKCβ inhibitor 1

CAS: 257879-35-9

PKCβ inhibitor 1 (KUN79359)(KUN79359) is a potent, selective and ATP-competitive inhibitor of PKC isozymes(IC50s of 21 and 5 nM for human PKCβ1 and PKCβ2,

Formel: C₂₄H₂₁N₅O₂

Reinheit: 99.33%

Farbe und Form: Yellow Solid

Molekulargewicht: 411.4558

Ref: TM-T8376

PKCβ inhibitor 1

CAS: 257879-35-9

3-(1-(3-(1H-Imidazol-1-yl)propyl)-1H-indol-3-yl)-4-(phenylamino)-1H-pyrrole-2,5-dione

Formel: C₂₄H₂₁N₅O₂

Reinheit: 98%

Molekulargewicht: 411.46

Ref: IN-DG01192788

3-(1-(3-IMIDAZOL-1-YLPROPYL)-1H-INDOL-3-YL)-4-ANILINO-1H-PYRROLE-2,5-DIONE

CAS: 257879-35-9

Reinheit: 98%

Molekulargewicht: 411.4649963

Ref: 10-F844432

3-Anilino-4-[1-(3-imidazol-1-ylpropyl)indol-3-yl]pyrrole-2,5-dione

Kontrolliertes Produkt

CAS: 257879-35-9

Formel: C₂₄H₂₁N₅O₂

Farbe und Form: Neat

Molekulargewicht: 411.456

Ref: TR-A433470

PKCβ Inhibitor

CAS: 257879-35-9

Formel: C₂₄H₂₁N₅O₂

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 411.4558

Ref: IN-DA01G83B

PKC² inhibitor 1

CAS: 257879-35-9

PKC2 inhibitor 1 is a small molecule that inhibits the PKC2 signaling pathway. It has been shown to reduce the severity of diabetic neuropathy in mice by inhibiting cell death and neuronal degeneration. PKC2 inhibitor 1 also decreased atherosclerotic lesion formation in a pharmacological model of an experimental mouse. This drug can be used to treat congestive heart failure, locomotor activity, and autoimmune diseases such as type I diabetes mellitus.

Formel: C₂₄H₂₁N₅O₂

Reinheit: Min. 95%

Molekulargewicht: 411.46 g/mol

Ref: 3D-HKA87935